What is the optimal initiation timing of angiotensin converting enzyme inhibitor treatment for maximum benefits in acute myocardial infarction patients? / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 464-466, 2011.
Article
em En
| WPRIM
| ID: wpr-321483
Biblioteca responsável:
WPRO
ABSTRACT
Randomized clinical trials led to the clinical recommendation that angiotensin-converting enzyme inhibitors (ACEI) should be used as standard therapy in most patients experiencing an acute myocardial infarction (AMI). However, the optimal initiation timing of treatment, as well as the exact mechanisms, have not been completely resolved, especially with the development of reperfusion strategy after AMI. Earlier initiation of ACEI might be associated with more prompt recovery of left ventricular ejection fraction due to more rapid attenuation of negative remodeling.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fatores de Tempo
/
Inibidores da Enzima Conversora de Angiotensina
/
Ensaios Clínicos Controlados Aleatórios como Assunto
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Infarto do Miocárdio
Tipo de estudo:
Clinical_trials
/
Guideline
Limite:
Humans
Idioma:
En
Revista:
Chinese Medical Journal
Ano de publicação:
2011
Tipo de documento:
Article